Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses.
about
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study.Towards nanomedicines for neuroAIDS.Potential of polymeric nanoparticles in AIDS treatment and prevention.Nanostructure-based drug delivery systems for brain targeting.Topical drug delivery using chitosan nano- and microparticles.Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.Advances in brain targeting and drug delivery of anti-HIV therapeutic agents.Insights into direct nose to brain delivery: current status and future perspective.Nanotechnology: a magic bullet for HIV AIDS treatment.Nasal-nanotechnology: revolution for efficient therapeutics delivery.Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.Improving drug delivery technology for treating neurodegenerative diseases.Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy.Nanomaterials in controlled drug release.Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain deliveryIntranasal drug delivery of olanzapine-loaded chitosan nanoparticles.Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation.Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.
P2860
Q34383339-43CFCA8A-9C54-4027-AA2B-9721002BD060Q34488285-37DE554C-C7C2-4CD8-B8A6-054BFCB5C76AQ34495140-373D67C2-A8F1-4C12-9609-B3F17BBE3D0BQ37818325-6EBD4DF0-1103-47A2-8DAD-D1A3C8E322CBQ37939942-31E8701C-46D7-4BD8-B560-54E4AE91045EQ38024402-53B93334-8C3E-467B-B482-59D34B93D66AQ38075010-E4E02009-82F4-4E1A-84B4-A6573D1A1E0EQ38091126-CD99CB44-405B-4C1E-814F-BEDAC9964975Q38150429-9BACABB9-9E8C-456E-91F9-0EAA0703920CQ38190581-C1C6AA95-066A-4A30-BCCD-C814D82A918CQ38217878-24383F2D-ED36-4E73-BF15-E9E76FF1AD13Q38706868-19AF457B-D10E-4174-A688-C02A51DAFFE5Q38769989-BC880AD3-08C9-4188-863D-B6CF84672A4FQ38879581-0C384150-4FD7-4878-A0ED-2E4056BAF5FDQ39243464-D03941AC-B98D-4BF0-B1B6-DC9CF189BF5FQ39733465-9A4E0884-6993-4B0D-8BC2-AC84F434FCB5Q40060003-9A78950E-721E-4C18-9355-1CF1209EF096Q40335819-4095D815-B591-409E-BA26-BA1C80D0D88BQ41690505-92865832-E802-4BCB-93C6-5D4309A288D2Q41849685-232AB0C3-53AA-4796-BAC8-07E2AE6BE0BBQ42005180-9E70BB2C-501C-48B5-90FD-F7961CD0BCD8Q48130937-6E1FFF11-29D9-4139-A45D-E5C2A3DC2329Q48284053-6C2DD129-6988-4C0D-A3C1-06AC54F829BFQ48960960-F01CEAB2-8D1E-43B0-AD79-CCEFF0E2F695Q52092764-9F8465D2-43A0-4AE8-888A-01D5B1BCB00F
P2860
Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Intranasal drug delivery of di ...... ctions caused by AIDS viruses.
@en
Intranasal drug delivery of di ...... ctions caused by AIDS viruses.
@nl
type
label
Intranasal drug delivery of di ...... ctions caused by AIDS viruses.
@en
Intranasal drug delivery of di ...... ctions caused by AIDS viruses.
@nl
prefLabel
Intranasal drug delivery of di ...... ctions caused by AIDS viruses.
@en
Intranasal drug delivery of di ...... ctions caused by AIDS viruses.
@nl
P2093
P2860
P1476
Intranasal drug delivery of di ...... ctions caused by AIDS viruses.
@en
P2093
Abeer M Al-Ghananeem
Ahmad H Malkawi
Hayder Saeed
Rebecca Florence
Robert A Yokel
P2860
P304
P356
10.3109/10611860903483396
P577
2010-06-01T00:00:00Z